Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis.

Slides:

Advertisements

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Advertisements

Assessment of inflammation in noninfectious chronic maxillary sinusitis Pascal Demoly, MDa, Louis Crampette, MDb, Michel Mondain, MDb, Alison M. Campbell,

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Immune function in cigarette smokers who quit smoking for 31 days

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome Paul Steinberg, MDa, Bruce E.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Pharmacologic rationale for treating allergic and nonallergic rhinitis

Oral Phenylephrine HCl for Nasal Congestion in Seasonal Allergic Rhinitis: A Randomized, Open-label, Placebo-controlled Study Eli O. Meltzer, MD, Paul.

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials Javier Dibildox,

A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis William R. Lumry, MD Journal of.

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma Patrick Booms, MSca, David.

Asthma and increased bronchial responsiveness in elite athletes: Atopy and sport event as risk factors Ilkka J. Helenius, MDa, Heikki O. Tikkanen, MDb,

The effect of omalizumab on nasal allergic inflammation

Dana V. Wallace, MD, Mark S. Dykewicz, MD, David I

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

The prevalence of and risk factors for atopy in early childhood: A whole population birth cohort study Syed Mohammad Tariq, MRCP, Sharon Marie Matthews,

Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials Javier Dibildox,

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD

Practice Notes from the AAAI

Badrul A. Chowdhury, MD, PhD

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

Edwin A. Bronsky, MD, Howard Druce, MD, Steven R. Findlay, MD, Frank C

Product characteristics and pharmacokinetics of intranasal ipratropium bromide Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.

Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

Elephantiasis nostras: A case report

Conjunctivitis medicamentosa

Practice Notes from the AAAAI

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model John M.

Robert A. Wood, MD, Wanda Phipatanakul, MD, Robert G

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge Adriaan.

News & Notes Journal of Allergy and Clinical Immunology

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma Mamert Milewski, MD, Lucyna Mastalerz, MD, Ewa Niżankowska, MD, Andrzej.

Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years’ duration Kawa.

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma William.

Mary Elizabeth Bollinger, DO, Robert G. Hamilton, PhD, Robert A

Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray Eli O. Meltzer,

Molecular virology and immunology of HIV infection

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Model for outcomes assessment of antihistamine use for seasonal allergic rhinitis Robert P. Harvey, MD, Carolyn Comer, MD, Barbara Sanders, MD, Ross Westley,

Evaluation of devices for skin prick testing

Thomas B. Casale, MDa, I. Leonard Bernstein, MDb, William W

News & Notes Journal of Allergy and Clinical Immunology

A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

Assessment of inflammation in noninfectious chronic maxillary sinusitis Pascal Demoly, MDa, Louis Crampette, MDb, Michel Mondain, MDb, Alison M. Campbell,

The 30th anniversary of the American Board of Allergy and Immunology: Then and now Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.

Emma Broadfield, MRCP, Tricia M

News Beyond Our Pages Journal of Allergy and Clinical Immunology

The role and remediation of animal allergens in allergic diseases

Renata J. M. Engler, MDa, Julie Kenner, MD, PhDb, Donald Y. M

Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes Margerita M. Riccio, PhD, David.

Biology of nasal polyposis

Practice Notes from the AAAI

The natural progression of peanut allergy: Resolution and the possibility of recurrence David M. Fleischer, MDa, Mary Kay Conover-Walker, MSN, RN, CRNPa,

Anaphylaxis after initial ingestion of rambutan, a tropical fruit

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy Diane J. Pincus, MD, Teresa R. Humeston,

Footnotes1 Journal of Allergy and Clinical Immunology

Evelyn Farinas, RPh, MGA, Peter Honig, MD

Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis Teruo Shiomori, MDa, Shin-ichi Yoshida, MD, PhDb,

News & Notes Journal of Allergy and Clinical Immunology

Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal.

Presentation transcript:

Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications Jay Grossman, MD, Charles Banov, MD, Peter Boggs, MD, Edwin A. Bronsky, MD, Robert J. Dockhorn, MD, Howard Druce, MD, Steven R. Findlay, MD, John W. Georgitis, MD, Frank C. Hampel, MD, Harold Kaiser, MD, Paul Ratner, MD, David G. Tinkelman, MD, Martin D. Valentine, MD, Paul Roszko, RPha, Elena Zegarelli, PhDa, Chester Wood, MDa Journal of Allergy and Clinical Immunology Volume 95, Issue 5, Pages 1123-1127 (May 1995) DOI: 10.1016/S0091-6749(95)70216-4 Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician long-term global assessments of effectiveness of ipratropium bromide nasal spray in PNAR. Journal of Allergy and Clinical Immunology 1995 95, 1123-1127DOI: (10.1016/S0091-6749(95)70216-4) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician long-term global assessments of effectiveness of ipratropium bromide nasal spray in PNAR. Journal of Allergy and Clinical Immunology 1995 95, 1123-1127DOI: (10.1016/S0091-6749(95)70216-4) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician long-term global assessments of effectiveness of ipratropium bromide nasal spray in PNAR. Journal of Allergy and Clinical Immunology 1995 95, 1123-1127DOI: (10.1016/S0091-6749(95)70216-4) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 1 Patient and physician long-term global assessments of effectiveness of ipratropium bromide nasal spray in PNAR. Journal of Allergy and Clinical Immunology 1995 95, 1123-1127DOI: (10.1016/S0091-6749(95)70216-4) Copyright © 1995 Mosby, Inc. Terms and Conditions

FIG. 2 Assessment of quality of life after 1 year of long-term treatment with ipratropium bromide in patients with PNAR. Journal of Allergy and Clinical Immunology 1995 95, 1123-1127DOI: (10.1016/S0091-6749(95)70216-4) Copyright © 1995 Mosby, Inc. Terms and Conditions